144 related articles for article (PubMed ID: 33560712)
1. Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States.
Kunst N; Long JB; Xu X; Busch SH; Kyanko KA; Lindau ST; Richman IB; Gross CP
Med Care; 2021 May; 59(5):437-443. PubMed ID: 33560712
[TBL] [Abstract][Full Text] [Related]
2. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities.
Hunter SA; Morris C; Nelson K; Snyder BJ; Poulton TB
AJR Am J Roentgenol; 2017 May; 208(5):1171-1175. PubMed ID: 28177646
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
4. Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in Norway.
Moger TA; Swanson JO; Holen ÅS; Hanestad B; Hofvind S
Eur J Health Econ; 2019 Nov; 20(8):1261-1269. PubMed ID: 31399773
[TBL] [Abstract][Full Text] [Related]
5. Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016.
Khushalani JS; Ekwueme DU; Richards TB; Sabatino SA; Guy GP; Zhang Y; Tangka F
J Womens Health (Larchmt); 2020 Mar; 29(3):327-337. PubMed ID: 31613693
[No Abstract] [Full Text] [Related]
6. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes and Cost-Effectiveness of Breast Cancer Screening With Digital Breast Tomosynthesis in the United States.
Lowry KP; Trentham-Dietz A; Schechter CB; Alagoz O; Barlow WE; Burnside ES; Conant EF; Hampton JM; Huang H; Kerlikowske K; Lee SJ; Miglioretti DL; Sprague BL; Tosteson ANA; Yaffe MJ; Stout NK
J Natl Cancer Inst; 2020 Jun; 112(6):582-589. PubMed ID: 31503283
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old.
Richman IB; Long JB; Hoag JR; Upneja A; Hooley R; Xu X; Kunst N; Aminawung JA; Kyanko KA; Busch SH; Gross CP
J Natl Cancer Inst; 2021 Nov; 113(11):1515-1522. PubMed ID: 33822120
[TBL] [Abstract][Full Text] [Related]
9. Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models.
Fleming MM; Hughes DR; Golding LP; McGinty GB; MacFarlane D; Duszak R
J Am Coll Radiol; 2019 Jul; 16(7):902-907. PubMed ID: 30679104
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women.
Upneja A; Long JB; Aminawung JA; Kyanko KA; Kunst N; Xu X; Busch SH; Gross CP; Richman IB
J Gen Intern Med; 2022 Jun; 37(8):1870-1876. PubMed ID: 34595682
[TBL] [Abstract][Full Text] [Related]
11. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis.
Richman IB; Long JB; Kyanko KA; Xu X; Gross CP; Busch SH
JAMA Netw Open; 2022 Mar; 5(3):e224208. PubMed ID: 35333358
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
13. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.
Gilbert FJ; Tucker L; Gillan MG; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Lim YY; Purushothaman H; Strudley C; Astley SM; Morrish O; Young KC; Duffy SW
Health Technol Assess; 2015 Jan; 19(4):i-xxv, 1-136. PubMed ID: 25599513
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.
Sankatsing VDV; Juraniec K; Grimm SE; Joore MA; Pijnappel RM; de Koning HJ; van Ravesteyn NT
Radiology; 2020 Oct; 297(1):40-48. PubMed ID: 32749212
[TBL] [Abstract][Full Text] [Related]
15. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
16. Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population.
Bonafede MM; Kalra VB; Miller JD; Fajardo LL
Clinicoecon Outcomes Res; 2015; 7():53-63. PubMed ID: 25624767
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System.
Alsheik NH; Dabbous F; Pohlman SK; Troeger KM; Gliklich RE; Donadio GM; Su Z; Menon V; Conant EF
Acad Radiol; 2019 May; 26(5):597-605. PubMed ID: 30057195
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice.
Greenberg JS; Javitt MC; Katzen J; Michael S; Holland AE
AJR Am J Roentgenol; 2014 Sep; 203(3):687-93. PubMed ID: 24918774
[TBL] [Abstract][Full Text] [Related]
19. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
